AbCellera Biologics Inc (ABCL)
2.715
-0.16
(-5.73%)
USD |
NASDAQ |
Nov 05, 16:00
2.715
0.00 (0.00%)
After-Hours: 16:16
AbCellera Biologics Profit Margin (Quarterly): -504.3% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -504.3% |
| March 31, 2024 | -408.0% |
| December 31, 2023 | -513.7% |
| September 30, 2023 | -433.6% |
| June 30, 2023 | -303.6% |
| March 31, 2023 | -329.0% |
| December 31, 2022 | -138.7% |
| September 30, 2022 | 26.26% |
| June 30, 2022 | -14.78% |
| March 31, 2022 | 53.25% |
| Date | Value |
|---|---|
| December 31, 2021 | 43.03% |
| September 30, 2021 | -388.2% |
| June 30, 2021 | -8.40% |
| March 31, 2021 | 57.82% |
| December 31, 2020 | 56.28% |
| September 30, 2020 | -28.77% |
| June 30, 2020 | 59.70% |
| March 31, 2020 | -44.94% |
| December 31, 2019 | -51.24% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-513.7%
Minimum
Dec 2023
59.70%
Maximum
Jun 2020
-151.1%
Average
-44.94%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
| Grace Therapeutics Inc | -- |
| Aurinia Pharmaceuticals Inc | 1.26% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.12K% |
| InMed Pharmaceuticals Inc | -151.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -13.28% |
| Return on Assets | -10.34% |
| Return on Invested Capital | -13.28% |
| Operating Margin (Quarterly) | -1.23K% |
| Return on Net Operating Assets | -28.54% |